Literature DB >> 8789383

Functional characterization of adenosine receptors in the nucleus tractus solitarius mediating hypotensive responses in the rat.

P J White1, R B Rose'Meyer, W Hope.   

Abstract

1. The aim of this study was to characterize adenosine receptors located in the nucleus tractus solitarius (NTS) that mediate decreases in blood pressure in the anaesthetized rat. To determine the adenosine receptor subtype involved, a range of selective agonists and antagonists were studied and their relative potencies evaluated. 2. The rank order of agonist potency in inducing decreases in diastolic blood pressure was N6-cyclopentyladenosine (CPA) > N6-cyclohexyladenosine (CHA) > N-ethyl-carboxamidoadenosine (NECA) > or = 2-phenylaminoadenosine (CV1808) > 2-p-(carboxyethyl)phenethylamino-5' N-ethylcarboxamidoadenosine (CGS 21680) > N6-(2-(4-aminophenyl)ethyl)-adenosine (APNEA). 3. The hypotensive action of CPA following microinjection into the NTS was antagonized by i.v. infusions (50 micrograms kg-1 min-1) of adenosine receptor antagonists, 8-cyclopentyl-1,3 dipropylxanthine (DPCPX), 8-phenyltheophylline (8-PT), 8-(p-sulphophenyl)theophylline (8-SPT), and 1,3-dipropyl-8-N-(2-diethylamino)ethyl)-N methyl-4-(2,3,6,7-tetrahydro-2,6-dioxo) benzenesulphonamidexanthine (PD 115199). The antagonist potency order was DPCPX > PD115199 > or = 8-PT. Intravenous infusion of 8-SPT had no effect on blood pressure responses to microinjection of CPA into the NTS. 4. The results suggest that adenosine A1 receptors in the NTS mediate hypotensive responses in the anaesthetized rat preparation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8789383      PMCID: PMC1909260          DOI: 10.1111/j.1476-5381.1996.tb15191.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells.

Authors:  D van Calker; M Müller; B Hamprecht
Journal:  J Neurochem       Date:  1979-11       Impact factor: 5.372

Review 2.  Adenosine antagonists.

Authors:  M Williams
Journal:  Med Res Rev       Date:  1989 Apr-Jun       Impact factor: 12.944

Review 3.  Adenosine receptor subtypes.

Authors:  M G Collis; S M Hourani
Journal:  Trends Pharmacol Sci       Date:  1993-10       Impact factor: 14.819

4.  Diminished purinergic modulation of the vascular adrenergic neurotransmission in spontaneously hypertensive rats.

Authors:  Y Kamikawa; W H Cline; C Su
Journal:  Eur J Pharmacol       Date:  1980-09-05       Impact factor: 4.432

5.  Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines.

Authors:  J W Daly; P Butts-Lamb; W Padgett
Journal:  Cell Mol Neurobiol       Date:  1983-03       Impact factor: 5.046

6.  Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.

Authors:  R F Bruns; G H Lu; T A Pugsley
Journal:  Mol Pharmacol       Date:  1986-04       Impact factor: 4.436

7.  Neuronal and cardiovascular responses to adenosine microinjection into the nucleus tractus solitarius.

Authors:  S Tao; A A Abdel-Rahman
Journal:  Brain Res Bull       Date:  1993       Impact factor: 4.077

8.  Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl)theophylline.

Authors:  G Evoniuk; R W von Borstel; R J Wurtman
Journal:  J Pharmacol Exp Ther       Date:  1987-02       Impact factor: 4.030

9.  Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex.

Authors:  I von Kügelgen; L Späth; K Starke
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

10.  Action of adenosine receptor antagonists on the cardiovascular response to defence area stimulation in the rat.

Authors:  J H St Lambert; M S Dawid-Milner; L Silva-Carvalho; K M Spyer
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

View more
  4 in total

1.  The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity.

Authors:  David Blum; David Gall; Marie-Christine Galas; Pablo d'Alcantara; Kadiombo Bantubungi; Serge N Schiffmann
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

2.  The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices.

Authors:  A M Pugliese; C Traini; S Cipriani; M Gianfriddo; T Mello; M G Giovannini; A Galli; F Pedata
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

Review 3.  Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy.

Authors:  Nina Wolska; Marcin Rozalski
Journal:  Int J Mol Sci       Date:  2019-11-03       Impact factor: 5.923

Review 4.  Adenosine A2A receptors modulate acute injury and neuroinflammation in brain ischemia.

Authors:  Felicita Pedata; Anna Maria Pugliese; Elisabetta Coppi; Ilaria Dettori; Giovanna Maraula; Lucrezia Cellai; Alessia Melani
Journal:  Mediators Inflamm       Date:  2014-08-05       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.